TAKE CARE OF YOU AND YOUR PRACTICE DURING THIS PANDEMIC. WE ARE HERE TO HELP!

copd

FDA Approves Symbicort
March 17, 2022

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicine This week, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health conditions: asthma in patients six years of age…

FDA Approves Symbicort
COPD Heart Failure
February 16, 2022

Study Finds Differences in Patients With Both COPD, Heart Failure

Patients with both heart failure (HF) and chronic obstructive pulmonary disease (COPD) face a unique set of challenges and impairments compared with those with just one of the diseases, according to a new report. The study, published in Scientific Reports, offers new insights to help physicians better treat patients with overlapping conditions. Corresponding author Audrey Borghi-Silva, PhD, MSc, of the…

COPD Heart Failure
Iron COPD
January 19, 2022

Study: Excess Iron Linked with COPD Exacerbation

Evidence suggests higher levels of iron in pulmonary macrophages heightens the risk of infectious exacerbations. A new report yielded fresh insights into the role of pulmonary iron in chronic obstructive pulmonary disease (COPD), suggesting that excess iron in pulmonary macrophages may increase the risk of recurrent airway infection. Writing in the journal Respiratory Research, corresponding author…

Iron COPD
Rome Proposal
January 05, 2022

‘Rome Proposal’ Sets Framework for Classifying COPD Exacerbations

An international team of researchers has published a new framework, dubbed the Rome proposal, for defining and classifying exacerbations of chronic obstructive pulmonary disease (COPD). “The ‘Rome Proposal’ represents an important milestone for better understanding and treating a very important and troubling component of COPD progression and, the prospect for more accurate treatment and better…

Rome Proposal
covid-19 vaccine
September 14, 2021

What People with Asthma Need to Know About COVID-19 Vaccines

Millions of people around the world have been vaccinated against COVID-19. Most people experience mild or no side effects after vaccination. Severe side effects are rare for the three COVID-19 vaccines approved in the United States. Currently, the latest scientific evidence suggests that people with asthma are not at an elevated risk of developing side…

covid-19 vaccine
COPD Outlook
September 02, 2021

COPD Life Expectancy and Outlook

Millions of adults in the United States have chronic obstructive pulmonary disease (COPD), and just as many are developing it. But many of them are unaware, according to the National Heart Lung and Blood Institute. One question many people with COPD have is, “How long can I live with COPD?” There’s no way to predict the exact…

COPD Outlook
COPD Progression
August 20, 2021

Does COPD Progress After Quitting Smoking?

If your patients have chronic obstructive pulmonary disease (COPD), you may be thinking about having them quit smoking a little more seriously. There are proven benefits to quitting smoking. It can help improve symptoms and slow the progression of COPD. After hours, days, months, and years of quitting, there are benefits for the lungs and…

COPD Progression
Anxiety COPD
June 30, 2021

Anxiety Treatments Can Help People with COPD Breathe a Little Easier

Cognitive behavioral therapy can help people with COPD deal with the anxiety associated with breathing difficulties. Relaxation techniques are among the therapies people with COPD can use for anxiety. Imagine not being able to breathe easily. You’d probably be a little anxious. That’s what happens to many of the 12 million adults in the United States…

Anxiety COPD